http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100896826-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-01 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100896826-B1 |
| titleOfInvention | Antibiotic 7071, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and uses thereof |
| abstract | The present invention provides antibiotics of microbial origin (optionally designated as antibiotic 107891) produced by fermentation of Microbispora species ATCC PTA-5024, pharmaceutically acceptable salts and compositions thereof, and inhibitory activity against susceptible microorganisms. It relates to their use as an antimicrobial agent. Antibiotic 107891, a complex comprising two factors (named Factors A1 and A2), has a peptide structure containing lanthionine and methyllanthionine as components, typical of antibiotics of the lantibiotic group. Antibiotics 107891 and its factors A1 and A2 show good antimicrobial activity against Gram-positive bacteria, including methicillin resistant and vancomycin resistant strains, and some Gram-negative bacteria such as M. a. M. catharralis, Neisseria spp. And H. It is also active against influenzae (H. influenzae) and mycobacteria (Mycobacteria). n n Antibiotics 107891, Factors A1 and A2, Peptides, Microbispora, Methicillin, Vancomycin |
| priorityDate | 2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 284.